SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLTR COULTER PHARMACEUTICAL -- Ignore unavailable to you. Want to Upgrade?


To: Vector1 who wrote (539)3/29/2000 10:35:00 AM
From: Russian Bear  Read Replies (2) | Respond to of 666
 
I would be very curious to know the reasoning behind this:

Wednesday March 29, 10:25 am Eastern Time

RESEARCH ALERT - Prudential cuts Coulter

NEW YORK, March 29 (Reuters) - Prudential Securities said on Wednesday it reduced its
rating on Coulter Pharmaceutical Inc. (NasdaqNM:CLTR - news) to accumulate from strong
buy.

-- Coulter shares fell three to 39 in early trade on the Nasdaq.

-- Further details about the ratings cut from analyst Robert Toth were not immediately available.

RB